AZA decreased AQP1protein content by promoting AQP1 degradation. by Jianzhao Zhang (133200)

Specific sequence of A2PP decreases <i>M</i>. <i>hyorhinis</i> infection. by Shiqin Yuan (848670)

IFN-γ decreased viability of melanocytes, caused apoptosis and cell cycle arrest. by Suiquan Wang (544573)

Treatment with HBOT or PFD decreased HIF-1α expression in the AD lesions. by Hyung-Ran Kim (532404)

Fullerol treatment decreased the accumulation of leukocytes in the liver at 20 days after transplant. by Priscila T. T. Bernardes (559311)

Mechanical acupuncture by MAI decreases cocaine-induced locomotor activity in a stimulus time-dependent manner. by Seol Ah Kim (486416)

Mst1^−/− mice exhibit decreased incidence and severity of CIA. by Konstantin V. Salojin (567844)

LAMP1 decreased within MoDCs infected with <i>P. gingivalis</i> expressing Mfa1. by Ahmed R. El-Awady (697683)

Treatment with con-G showed improved neurological scoring and decreased peri-infarct Ca²⁺ microdeposits. by Rashna Balsara (714796)

TG6-44 treatment leads to a decrease in NP-positive cells and altered expression patterns of NP in A/X31 infected THP-1 cells. by Juan A. De La Cruz (11154187)

Decreased muscle strength is associated with proinflammatory cytokines but not testosterone levels in men with diabetes by J.P. Ferreira (5550653)

S100A12 decreased SAA-induced ERK1/2 and MEK1/2 phosphorylation. by Yuen Ming Chung (406571)

Mutation of stathmin phosphorylation sites decreases sensitivity to bortezomib and influences tubulin polymerization. by Feng Ge (64593)

Doxorubicin (DOXO) decreases STMN1 and increases TTP in HTR-8 cells. by Xiao-Ling Ma (4179232)

Decreased bacterial burden in mice with T-cell targeted deletion of HIF-1 α. by Manfred Thiel (310810)

The mRNA expression levels of Mfsd2a in brain microvessels from 2- and 24-month-old mice. by Takuro Iwao (14636741)

Subjects:

Brain uptake of [³H]mannitol in 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

Subjects:

MFSD2A expression levels in brain microvessels from 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

Subjects:

The decrease of ULK1 expression by miR-17-5p from BCG infection. by Xiangguo Duan (423329)

Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

“…<i>(B)</i> When the antagonist is administrated twice, intraocular pressure remains low during 6 weeks (n = 10 each); the black arrow indicates the period of retinal and visual <i>in vivo</i> testing presented in <i>Fig. 6A,B</i>. <i>(C)</i> Dose-dependent effect of two administrations of CXCR3 antagonist on intraocular pressure as tested two weeks after the treatment (n = 5 each). * <i>P</i><0.05, ** <i>P</i><0.01. …”